Clinical Trials Directory

Trials / Unknown

UnknownNCT03298347

Caffeine for Preterm Infants With Apnea of Prematurity(AOP)

Caffeine for Preterm Infants With Apnea of Prematurity(AOP): a Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
1 Minute – 1 Month
Healthy volunteers
Not accepted

Summary

Nowadays,caffein is commonly used for AOP, and it reduces the intubation rate in preterm infants. However, intubation is needed in about 20%-50% of partial neonates. How to reduce the intubation rate effectively is a challenge for neonatologists.

Detailed description

Less evidences about more dose of caffein used in preterm infants.

Conditions

Interventions

TypeNameDescription
DRUG80mg/kg of caffeine80mg/kg of caffeine is given to treat AOP
DRUG20mg/kg of caffeine20mg/kg of caffeine is given to treat AOP

Timeline

Start date
2017-10-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2017-10-02
Last updated
2017-10-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03298347. Inclusion in this directory is not an endorsement.

Caffeine for Preterm Infants With Apnea of Prematurity(AOP) (NCT03298347) · Clinical Trials Directory